HLA-A*2402-restricted CDCA1-A24-56 peptide vaccine

{
  "id": "MLC-T-ONC-014137",
  "term": "HLA-A*2402-restricted CDCA1-A24-56 peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine containing the HLA-A*2402-restricted peptide epitope derived from cell division associated gene 1 (CDCA1), with potential immunostimulatory and antitumor activities. Upon administration, HLA-A*2402-restricted CDCA1-A24-56 peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against CDCA1-expressing tumor cells, resulting in tumor cell lysis and decreased tumor cell proliferation. HLA-A*2402 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*2402 may improve antigenic peptide immunogenicity.",
  "synonyms": [
    "HLA-A*2402-restricted cell division cycle associated 1-A24-56 peptide vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/hla-a-2402-restricted-cdca1-a24-56-peptide-vaccine/"
}